Fed. Circ. Nixes Fetal DNA Test Patent Under Myriad, Mayo
The Federal Circuit on Friday affirmed a ruling that Sequenom Inc.'s patent for prenatal DNA tests used to determine the gender of a fetus is not patent-eligible because it is directed...To view the full article, register now.
Already a subscriber? Click here to view full article